Patient-Centered, Team-Based Continuing Care After Breast Cancer Treatment: The ConnectedCancerCare Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Early-stage Breast Cancer
- Sponsor
- University of Michigan Rogel Cancer Center
- Enrollment
- 66
- Locations
- 1
- Primary Endpoint
- Number of Breast Cancer Patients Successfully Recruited to Participate in the Study
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This study is an NCI-funded, randomized control pilot trial to evaluate: (1) the feasibility and acceptability of a web-based, personalized navigation tool (ConnectedCancerCare) and (2) explore whether the tool improves delivery of team-based survivorship care for women who have recently finished primary breast cancer treatment.
Detailed Description
This study is a randomized control pilot trial involving 60 women newly diagnosed with early-stage breast cancer who are finishing primary treatment. Participants will be randomized either to the intervention arm (CCC website that provides information on team-based follow-up care for both cancer surveillance and preventive care) or the control arm (static online survivorship care plan template, adapted from the ASCO breast cancer survivorship template). The feasibility and acceptability of the tool and correlations with patient-reported outcomes will be assessed 3 months following the completion of a baseline survey via an online follow-up survey.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosed with early Stage (0-IIB) breast cancer
- •Must be a patient of a University of Michigan Breast Cancer Oncologist
- •Must be completing primary cancer treatment and transitioning into survivorship
- •Must be able to speak, read and write in English
- •Must have access and the ability to use the internet
Exclusion Criteria
- •Diagnosed with stage III or IV breast cancer
- •Unable to speak, read, and write in English
Outcomes
Primary Outcomes
Number of Breast Cancer Patients Successfully Recruited to Participate in the Study
Time Frame: At baseline survey
We anticipate a response rate of 80% enrollment (n=60). We will assess the number of patients successfully recruited who enroll and complete the baseline survey.
Secondary Outcomes
- Percentage of Patients That Communicated With PCP About Provider Roles(3 months)
- Percentage of Patients Reporting a Preference for an Oncologist vs. PCP for Their Continuing Cancer Care Services(3 months)
- Patient-Reported Satisfaction With Oncologist/PCP Coordination of Care(3 months)
- Percentage of Patients Scheduling a Primary Care Physician (PCP) Appointment(3 months)
- Rating the Experience With the CCC Web-based, Survivorship Care Plan(Follow-Up Survey: 3 months)
- Knowledge About Team-based Survivorship Care(3 months)